KLEE JUSTIN B. (Co-Chief Executive Officer) received a stock award from AMYLYX PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/21/2026ACC: 0001193125-26-359678
DirectorOfficer· Co-Chief Executive Officer
Since Jan 2022
+60.04K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
60.04K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+60.04K
Price / share
—
Trade value
—
% of position
1.7%
8/18/2026
3.58M→3.64M
Total
Net shares
+60.04K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2026 | A · Award | +60.04K | — | — | 1.7% | 3.58M | 3.64M |
| Total | +60.04K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported